Left ventricular global longitudinal strain

Biomarker

2 papers2 findings

  • Humans2

Interventions

1

SGLT2 inhibitors

upin humans1

1 study
  1. SGLT2 inhibitors improve left ventricular global longitudinal strain in humans (-2.49% ± 0.54% vs. -0.44% ± 0.52%).

    Humansin patients with HFpEF6 months

    Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis

    Frontiers in cardiovascular medicine21 Jul 2026

More on SGLT2 inhibitors

Associations

1

Obesity

upin humans1

1 study
  1. Obesity is associated with left ventricular global longitudinal strain in humans (-22.7 ± 6.1% vs. -23.4 ± 4.2%).

    Humansoverweight/obese individuals versus age-sex-matched controls; preserved ejection fractionleft ventriclen = 60

    Even short-term obesity leads to subclinical dysfunction of both ventricles in young individuals

    Wiener klinische Wochenschrift9 Oct 2026

More on Obesity

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 2Oct 2026: 15 in 12 months